✦ LIBER ✦

Comparison of Tirazone (Tirapazamine) and cisplatin vs. etoposide and cisplatin in advanced non-small cell lung cancer (NSCLC): Final results of the international Phase III CATAPULT II Trial

✍ Scribed by Shepherd, F; Koschel, G; von Pawel, J; Gatzmeier, U; Van Zandwiyk, N; Woll, P; Van Klavren, R; Krasko, P; Desimone, P; Nicolson, M; Pieters, W; Bigelow, R; Rey, A; Viallet, J; Loh, E

Book ID: 118569632
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 119 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80087-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

28 Results of a phase III trial comparin

28 Results of a phase III trial comparing taxol-cisplatin (TC) regimens to etoposide-cisplatin (EC) in non-small cell lung cancer (NSCLC)

✍ Bonomi, P.; Kim, C.; Kugler, K.; Johnson, D. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 128 KB

P-202 Phase II trial of tirapazamine in

P-202 Phase II trial of tirapazamine in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer (NSCLC)

✍ Reck, Martin; von Pawel, Joachim; Nimmermann, Christa; Groth, Gesine; Gatzemeier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Cisplatin and etoposide (PE) vs cytoxan

Cisplatin and etoposide (PE) vs cytoxan and etoposide (CE) in the chemotherapy (CT) of advanced non small cell lung cancer (NSCLC)

📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Phase II trial assessing the combination

Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)

✍ Antón, A; Dı́az-Fernández, N; González Larriba, J.L; Vadell, C; Masutti, B; Mont 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Phase II study of the combination of vin

Phase II study of the combination of vinorelbine, cisplatin, and tirapazamine in inoperable non-small cell lung cancer (NSCLC)

✍ Le Chevalier, T; Gatineau, M; Daniel, C; Rixe, O; Pailler, M.-C; Fizazi, K; Font 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Cisplatin-gemcitabine-vinorelbine (PGV)

Cisplatin-gemcitabine-vinorelbine (PGV) vs cisplatin-vinorelbine (PV) vs cisplatin-gemcitabine (PG) in advanced non-small cell lung cancer (NSCLC). Interim analysis of a SICOG phase III trial

✍ P. Comella; N. Panza; G.P. Nicolella; L. Manzione; V. Lorusso; R. Cioffi; G. Dec 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB